Kyorin Pharmaceutical Co.,ltd.TSE: 4569

KYORIN Pharmaceutical: Strong Q1 profit growth, but full-year outlook projects lower sales and earnings

· Issued by Kyorin Pharmaceutical Co.,ltd.

Net sales and profits saw strong year-over-year growth in the first quarter, with EPS more than doubling. However, full-year forecasts anticipate declines in sales and profits, while the annual dividend is expected to remain unchanged.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Kyorin Pharmaceutical Co.,ltd

All Kyorin Pharmaceutical Co.,ltd news releases